EVESOR: a Phase 1 Trial of Everolimus and Sorafenib

NCT01932177 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Metastatic or Locally Advanced Solid Tumors

Interventions

DRUG: Everolimus and sorafenib
DRUG: Everolimus and sorafenib
DRUG: Everolimus and sorafenib
DRUG: Everolimus and sorafenib

Sponsor

Hospices Civils de Lyon